Fellow of The Academy of Medical Sciences, United Kingdom
Joyce Taylor-Papadimitriou mostly deals with Molecular biology, Antibody, Mucin, Monoclonal antibody and Epitope. Her Molecular biology research includes elements of Glycosylation, Complementary DNA, Gene, MUC1 and Tandem repeat. Joyce Taylor-Papadimitriou combines subjects such as Breast cancer, Antigen and Keratin with her study of Antibody.
In her research, Vimentin, In vitro, Hepatocyte growth factor, Integrin alpha3beta1 and Integrin is intimately related to Cell culture, which falls under the overarching field of Mucin. The concepts of her Monoclonal antibody study are interwoven with issues in Epithelium, Pathology, Polyclonal antibodies and Advanced disease. Joyce Taylor-Papadimitriou has included themes like Humoral immunity, Peptide sequence, Cancer research and Adenocarcinoma in her Epitope study.
Joyce Taylor-Papadimitriou spends much of her time researching Molecular biology, Antibody, MUC1, Mucin and Antigen. Her studies deal with areas such as Cell culture, Biochemistry, Gene and Interferon as well as Molecular biology. Her is doing research in Monoclonal antibody and Epitope, both of which are found in Antibody.
As a member of one scientific family, she mostly works in the field of Monoclonal antibody, focusing on Pathology and, on occasion, Scintigraphy. Her MUC1 research incorporates elements of Glycosylation and Tandem repeat. Her studies in Immunology integrate themes in fields like Cancer research and Cell biology.
Joyce Taylor-Papadimitriou focuses on Cancer research, Molecular biology, MUC1, Glycosylation and Antibody. Her Cancer research research incorporates elements of Breast cancer and Mammary gland. Her research in Molecular biology intersects with topics in Repressor, Gene, Monoclonal antibody and Antigen.
In the field of Mucin and Cancer she studies MUC1. Her study in Glycosylation is interdisciplinary in nature, drawing from both Gene expression, Glycosyltransferase, Glycan, Cell biology and Selectin. Her Antibody research is classified as research in Immunology.
Her main research concerns Molecular biology, MUC1, Glycosylation, Antibody and Cell biology. Her Molecular biology research incorporates themes from Promoter, Gene and Repressor. Her MUC1 study contributes to a more complete understanding of Antigen.
As part of the same scientific family, Joyce Taylor-Papadimitriou usually focuses on Glycosylation, concentrating on Mucin and intersecting with SIGLEC, Cancer cell, Tumor microenvironment and Calcium flux. Her Epitope and Isotype study in the realm of Antibody interacts with subjects such as Glycopeptide. Her Epitope research is multidisciplinary, incorporating perspectives in Humoral immunity, Monoclonal antibody, Tandem repeat and Polyclonal antibodies.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Molecular cloning and expression of human Tumor-associated Polymorphic Epithelial Mucin
S.J. Gendler;C.A. Lancaster;J. Taylor-Papadimitriou;T. Duhig.
Journal of Biological Chemistry (1990)
Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.
Joyce Taylor-Papadimitriou;J. A. Peterson;J. Arklie;Joy Burchell.
International Journal of Cancer (1981)
A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.
Sandra Gendler;Joyce Taylor-Papadimitriou;Trevor Duhig;Jonathan Rothbard.
Journal of Biological Chemistry (1988)
MUC1 and cancer
J Taylor-Papadimitriou;J Burchell;D.W Miles;M Dalziel.
Biochimica et Biophysica Acta (1999)
Development and Characterization of Breast Cancer Reactive Monoclonal Antibodies Directed to the Core Protein of the Human Milk Mucin
Joy Burchell;Sandra Gendler;Joyce Taylor-Papadimitriou;Anne Girling.
Cancer Research (1987)
TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURS
A.A. Epenetos;A.A. Epenetos;S. Mather;S. Mather;M. Granowska;M. Granowska;C.C. Nimmon;C.C. Nimmon.
The Lancet (1982)
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.
Keith R. Jerome;Donna L. Barnd;Katharine M. Bendt;Cinda M. Boyer.
Cancer Research (1991)
PLU-1 Is an H3K4 Demethylase Involved in Transcriptional Repression and Breast Cancer Cell Proliferation
Kenichi Yamane;Keisuke Tateishi;Robert J. Klose;Jia Fang.
Molecular Cell (2007)
Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines: DEMONSTRATION OF SIMPLER AND FEWER GLYCAN CHAINS IN TUMOR CELLS
Kenneth O. Lloyd;Joy Burchell;Valery Kudryashov;Beatrice W.T. Yin.
Journal of Biological Chemistry (1996)
A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas.
Anne Girling;Jirina Bartkova;Joy Burchell;Sandra Gendler.
International Journal of Cancer (1989)
Seminars in Cancer Biology
(Impact Factor: 17.012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: